Trials / Not Yet Recruiting
Not Yet RecruitingNCT07513857
Trial of JYB1904 Injection in Adolescent Participants
A Multicenter, Single-arm, Phase Ib Clinical Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity Profiles of JYB1904 Injection in Adolescent Participants Aged 12-17 Years
- Status
- Not Yet Recruiting
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 12 (estimated)
- Sponsor
- Jemincare · Industry
- Sex
- All
- Age
- 12 Years – 17 Years
- Healthy volunteers
- Not accepted
Summary
This Phase Ib Trial is Meant to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity Profiles of JYB1904 Injection in Adolescent Participants With Allergic Diseases.
Detailed description
This Study is a multicenter, single-arm, Phase Ib clinical study to evaluate the safety, pharmacokinetics, pharmacodynamics, and immunogenicity profiles of JYB1904 injection in adolescent participants aged 12-17 years
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | JYB1904 | Received a single 300 mg JYB1904 injection administered subcutaneously(SC) at D1 |
Timeline
- Start date
- 2026-05-17
- Primary completion
- 2027-07-30
- Completion
- 2027-07-30
- First posted
- 2026-04-07
- Last updated
- 2026-04-07
Source: ClinicalTrials.gov record NCT07513857. Inclusion in this directory is not an endorsement.